vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and REGIS CORP (RGS). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $57.1M, roughly 1.1× REGIS CORP). REGIS CORP runs the higher net margin — 0.8% vs -70.9%, a 71.7% gap on every dollar of revenue. On growth, REGIS CORP posted the faster year-over-year revenue change (22.3% vs 8.1%). REGIS CORP produced more free cash flow last quarter ($891.0K vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 7.8%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
CTKB vs RGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $57.1M |
| Net Profit | $-44.1M | $456.0K |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 10.8% |
| Net Margin | -70.9% | 0.8% |
| Revenue YoY | 8.1% | 22.3% |
| Net Profit YoY | -557.1% | -94.0% |
| EPS (diluted) | — | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $57.1M | ||
| Q3 25 | $52.3M | $59.0M | ||
| Q2 25 | $45.6M | $60.4M | ||
| Q1 25 | $41.5M | $57.0M | ||
| Q4 24 | $57.5M | $46.7M | ||
| Q3 24 | $51.5M | $46.1M | ||
| Q2 24 | $46.6M | $49.4M | ||
| Q1 24 | $44.9M | $49.2M |
| Q4 25 | $-44.1M | $456.0K | ||
| Q3 25 | $-5.5M | $1.4M | ||
| Q2 25 | $-5.6M | $116.5M | ||
| Q1 25 | $-11.4M | $250.0K | ||
| Q4 24 | $9.6M | $7.6M | ||
| Q3 24 | $941.0K | $-853.0K | ||
| Q2 24 | $-10.4M | $91.2M | ||
| Q1 24 | $-6.2M | $-2.3M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 10.8% | ||
| Q3 25 | -17.6% | 10.0% | ||
| Q2 25 | -23.3% | 12.1% | ||
| Q1 25 | -36.1% | 8.8% | ||
| Q4 24 | 5.2% | 11.8% | ||
| Q3 24 | -8.2% | 4.6% | ||
| Q2 24 | -18.3% | — | ||
| Q1 24 | -23.9% | 8.3% |
| Q4 25 | -70.9% | 0.8% | ||
| Q3 25 | -10.5% | 2.3% | ||
| Q2 25 | -12.2% | 192.9% | ||
| Q1 25 | -27.5% | 0.4% | ||
| Q4 24 | 16.8% | 16.4% | ||
| Q3 24 | 1.8% | -1.9% | ||
| Q2 24 | -22.4% | 184.7% | ||
| Q1 24 | -13.8% | -4.7% |
| Q4 25 | — | $0.16 | ||
| Q3 25 | — | $0.49 | ||
| Q2 25 | — | $43.67 | ||
| Q1 25 | — | $0.08 | ||
| Q4 24 | — | $2.71 | ||
| Q3 24 | — | $-0.36 | ||
| Q2 24 | — | $38.40 | ||
| Q1 24 | — | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $18.4M |
| Total DebtLower is stronger | — | $113.3M |
| Stockholders' EquityBook value | $341.7M | $188.7M |
| Total Assets | $461.5M | $588.3M |
| Debt / EquityLower = less leverage | — | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $18.4M | ||
| Q3 25 | $93.3M | $16.6M | ||
| Q2 25 | $75.5M | $17.0M | ||
| Q1 25 | $95.3M | $13.3M | ||
| Q4 24 | $98.7M | $10.2M | ||
| Q3 24 | $162.3M | $6.3M | ||
| Q2 24 | $177.9M | $10.1M | ||
| Q1 24 | $168.8M | $5.9M |
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
| Q4 25 | $341.7M | $188.7M | ||
| Q3 25 | $378.6M | $187.6M | ||
| Q2 25 | $377.6M | $185.6M | ||
| Q1 25 | $379.6M | $68.6M | ||
| Q4 24 | $395.7M | $66.7M | ||
| Q3 24 | $385.5M | $56.4M | ||
| Q2 24 | $389.1M | $56.8M | ||
| Q1 24 | $392.6M | $-35.8M |
| Q4 25 | $461.5M | $588.3M | ||
| Q3 25 | $494.9M | $592.1M | ||
| Q2 25 | $493.3M | $599.0M | ||
| Q1 25 | $482.6M | $511.2M | ||
| Q4 24 | $499.5M | $530.1M | ||
| Q3 24 | $491.2M | $508.9M | ||
| Q2 24 | $483.7M | $530.5M | ||
| Q1 24 | $492.1M | $543.7M |
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $1.7M |
| Free Cash FlowOCF − Capex | $-1.8M | $891.0K |
| FCF MarginFCF / Revenue | -2.9% | 1.6% |
| Capex IntensityCapex / Revenue | 1.6% | 1.4% |
| Cash ConversionOCF / Net Profit | — | 3.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $1.7M | ||
| Q3 25 | $-3.9M | $2.3M | ||
| Q2 25 | $108.0K | $6.8M | ||
| Q1 25 | $-125.0K | $6.2M | ||
| Q4 24 | $2.0M | $2.1M | ||
| Q3 24 | $13.2M | $-1.3M | ||
| Q2 24 | $6.2M | $5.1M | ||
| Q1 24 | $4.0M | $-277.0K |
| Q4 25 | $-1.8M | $891.0K | ||
| Q3 25 | $-4.6M | $1.9M | ||
| Q2 25 | $-1.5M | $6.2M | ||
| Q1 25 | $-974.0K | $5.9M | ||
| Q4 24 | $1.1M | $1.7M | ||
| Q3 24 | $12.2M | $-1.4M | ||
| Q2 24 | $5.2M | $5.1M | ||
| Q1 24 | $3.4M | $-326.0K |
| Q4 25 | -2.9% | 1.6% | ||
| Q3 25 | -8.7% | 3.2% | ||
| Q2 25 | -3.2% | 10.3% | ||
| Q1 25 | -2.3% | 10.3% | ||
| Q4 24 | 1.9% | 3.6% | ||
| Q3 24 | 23.7% | -3.0% | ||
| Q2 24 | 11.0% | 10.3% | ||
| Q1 24 | 7.6% | -0.7% |
| Q4 25 | 1.6% | 1.4% | ||
| Q3 25 | 1.3% | 0.7% | ||
| Q2 25 | 3.5% | 0.9% | ||
| Q1 25 | 2.0% | 0.6% | ||
| Q4 24 | 1.6% | 0.9% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 2.3% | 0.0% | ||
| Q1 24 | 1.3% | 0.1% |
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | 0.21× | 0.28× | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
